AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (June 16, 2006). doi:10.1152/ajpheart.00122.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/H2246    most recent
00122.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deo, S.
Right arrow Articles by Caffrey, J. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deo, S.
Right arrow Articles by Caffrey, J. L
Submitted on February 2, 2006
Accepted on June 9, 2006

REPEATED {delta}1-OPIOID RECEPTOR STIMULATION REDUCES {delta}2-OPIOID RECEPTOR RESPONSES IN THE SA NODE

Shekhar Deo1, Matthew A Barlow1, Shavsha Johnson-Davis1, Darice Yoshishige1, and James L Caffrey1*

1 Integrative Physiology/Cardiovascular Research Instirute, University of North Texas Health Science Center, Fort Worth, Texas, United States

* To whom correspondence should be addressed. E-mail: caffreyj{at}hsc.unt.edu.

Ultra-low doses (fmoles/min) of methionine-enkephalin-arginine-phenylalanine (MEAP) improve vagal transmission (vagotonic) and decrease heart rate by stimulating {delta}1-opioid receptors within the sinoatrial (SA) node. Higher doses of MEAP (nmoles/min) acting on {delta}2-opioid receptors interrupt vagal transmission (vagolytic) and reduce the decline in heart rate. Preconditioning-like occlusion of the nodal artery produced a vagotonic response that was reversed by the {delta}1-receptor antagonist BNTX. This study was designed to test the hypothesis that extended {delta}1-opioid receptor stimulation reduces {delta}2-opioid receptor responses. The vagi were isolated, ligated and the right vagus was stimulated to produce a two-step decline in heart rate. In study one, the {delta}2-agonist, deltorphin II was introduced into the SA node by microdialysis to evaluate the {delta}2-response before and after the infusion of the {delta}1-agonist, TAN-67. TAN-67 reduced the vagolytic effect of deltorphin by two thirds. In study two, the selective {delta}1-antagonist BNTX was combined with TAN-67. BNTX preserved the deltorphin response suggesting that attrition of the prior response was mediated by {delta}1-receptor activity. When TAN 67 was omitted in time control studies, some loss of the {delta}2-response was apparent in the absence of the {delta}1-agonist. This loss was also eliminated by the {delta}1-antagonist, BNTX suggesting that the attenuation following deltorphin was also due to {delta}1-activity. Additional studies were conducted to determine the effect of TAN-67 in the absence of prior deltorphin. When time controls were conducted without the initial deltorphin treatment a robust vagolytic response was observed. When this same deltorphin was preceded by TAN 67, the vagolytic response was significantly eroded. BNTX infused after loss of the {delta}2-response was unable to reverse the loss. These data support the conclusion that the loss of the {delta}2-response resulted from reduced {delta}2-activity mediated by continued {delta}1-receptor stimulation and not the arithmetic consequence of increased competition from that same {delta}1-activity




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey
Repeated Arterial Occlusion, Delta-Opioid Receptor (DOR) Plasticity and Vagal Transmission Within the Sinoatrial Node of the Anesthetized Dog
Experimental Biology and Medicine, January 1, 2009; 234(1): 84 - 94.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Davis, S. H. Deo, M. Barlow, D. Yoshishige, M. Farias, and J. L. Caffrey
The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of {delta}2-opioid receptor stimulation
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2318 - H2326.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.